PKM and colorectal carcinoma: Moreover, lncRNA XIST is demonstrated to promoting 5-FU/cisplatin-resistance and glycolysis in CRC by increasing the ratio of PKM2/PKM1, while miR-137 mimics can alleviate the facilitating effect of XIST (69).